| |
Significant patient populations, top clinical institutions, and ease of regulatory compliance combined to support oncology trial success in APAC. Download our white paper to explore the growth of oncology trials in APAC countries and strategies to support global study success in this dynamic and complex region. Premier Research. Built for Biotech℠ 
|
|
Today's Big NewsOct 20, 2022 |
|
Sino Biological offers rapid mouse monoclonal antibody development service on the Beacon®️ platform and obtains positive clones within 35 days, which accelerates the process of antibody (drug) discovery. Learn more. 
|
|
| By Gabrielle Masson Gene editing biotech Prime Medicine is turning up the heat, melting some of the frosty market waters with a $175 million IPO, one of the sector’s largest debuts this year, especially for a preclinical company with no human data to fuel fundraises. |
|
|
|
By James Waldron AbbVie is paying $255 million cash to acquire DJS Antibodies and the British biotech's platform for targeting transmembrane proteins. |
Sponsored By Cullinan Oncology Cullinan Oncology’s strategic approach to research and development, focusing on modality-agnostic target oncology, positions the company to thrive. |
Sponsored By PathAI TME research is recognized as one of the most promising areas in oncology drug development. AI-powered digital pathology reveals new insights previously hidden by laborious manual pathology methods. |
By Nick Paul Taylor Pfizer may have dodged a bullet by walking away from AM-Pharma. The biotech, a onetime takeover target for the Big Pharma, has stopped a phase 3 clinical trial of its kidney injury candidate early after it failed an interim futility analysis. |
By James Waldron Talaris Therapeutics has restarted its organ transplant trial after being assured that the circumstances behind a patient’s death this week won’t reoccur. |
By Nick Paul Taylor Roche is opening a new front in its targeting of KRAS-mutated cancer, agreeing to pay $25 million upfront and committing to up to $930 million in biobucks for the rights to Hookipa Pharma’s HB-700 and the option for another arenaviral immunotherapy. |
By Fraiser Kansteiner J&J is laying off 64 employees at its Johnson & Johnson Services plant on West 26th street in Manhattan. Around the same time, 51 New York-based Corning Pharmaceutical Technologies staffers are headed for the exit as the company downsizes its pharma packaging workforce in Big Flats. |
By Helen Floersh Scientists at Virginia Tech have discovered that the bacterium Fusobacterium nucleatum accelerates the growth of cells in pancreatic cancer cells, offering insights into potential new approaches to cancer therapies. |
By Joseph Keenan Veeva Systems has signed up 40 CROs to use its suite of clinical trial management tools as part of efforts to standardize systems to provide more efficient communications and operations. |
By Andrea Park Just a few weeks after racking up its fifth Class I recall from the FDA this year, Philips has hit the half-dozen mark. |
By Joseph Keenan The Association of Clinical Research Organizations rolled out a new element to its toolkit for decentralized clinical trials as part of the trade group’s efforts to speed up the adoption of digital and hybrid methods. |
By Andrea Park A study published this week highlights yet another area of potential racial bias in healthcare: end-stage heart failure therapies, where white patients were found to receive life-extending treatments at distinctly higher rates compared to Black patients. |
Fierce podcasts Don't miss an episode |
| This week on "Podnosis," we talk about the explosion of consumer-initiated lab testing. Also under discussion is our special report on the key issues and trends with Medicare Advantage. |
|
|---|
|
|
|
Wednesday, October 26, 2022 | 1pm ET / 10am PT In this webinar, we’ll explore how incorporating telehealth genetic screening into clinical trials can accelerate patient identification, recruitment and engagement. Register now. 
|
|
eBook Improve patient engagement, adherence, and outcomes Sponsored by: Health Catalyst |
Whitepaper Electronic health records (EHR) and patient registries are both important sources of real-world evidence – but which is right for your needs? Sponsored by: Veradigm Health |
Research Learn more about adaptive ascending dose escalation designs and considerations for determining the optimal approach to meet your drug development objectives Sponsored by: Allucent |
eBook Looking to implement a remote patient monitoring (RPM) program at your organization? Download the eBook from Health Catalyst to learn the essential components of successful RPM programs. Sponsored by: Health Catalyst |
eBook In this free guide, explore how Cloud Computing is enabling emerging biopharma organizations to decrease time-to-discovery in pursuit of breakthrough treatment modalities. Sponsored by: RCH Solutions |
eBook With real-world data playing a significant role in health care decisions, life sciences leaders need to maximize their data investments. The best place to start is right here, with our e-book on the four steps to a more coordinated, connected real-world data strategy. Sponsored by: Optum |
Whitepaper Learn the benefits of unlocking data insights across the healthcare and life sciences ecosystem. Sponsored by: NTT DATA |
Whitepaper SaaS LIMS from LabVantage Solutions Is Pre-Validated for Regulated Industries, Delivering Maximum Flexibility, Uptime, and Security. Sponsored by: LabVantage Solutions Inc. |
Whitepaper Read about key factors and trends in RWE and how our data luminaries are the right partner to lead the way forward. Sponsored by: Lumanity |
Whitepaper This paper is the first in a 4-part series focused on developing commercial models for gene therapies Sponsored by: Blue Matter, strategic consultants in the life sciences |
Video Learn how a centralized platform for pathology images, metadata, and analysis results can connect previously siloed research initiatives and advance our collective understanding of tissue. Sponsored by: Proscia |
Video Can an optimized research process--including AI-powered workflow and process automation tools--help get breakthrough drugs to market faster? Sponsored by: Proscia |
Whitepaper What is the most suitable dosage form technology for the Oral Delivery of Lipid-Based Formulations? Sponsored by: Catalent |
Research Learn more about how the versatility of Softgel Technology helped a customer with a volatile compound. Sponsored by: Catalent |
Whitepaper How can Lipid-Based Drug Delivery System help bring poorly soluble drugs to market? Sponsored by: Catalent |
Whitepaper Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care. Sponsored by: Catalent Biologics |
Webinar Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar. Sponsored by: Catalent Biologics |
Custom Resource Center Read through this library of resources to find out how you can strengthen innovation and efficiency, improve safety and quality, and prioritize resources to support your long-term goals. Sponsored by: JLL |
Whitepaper Clarus Therapeutics (Clarus) is a men’s specialty pharmaceutical company that partnered with Catalent to develop a unique and convenient drug delivery form for their hormone replacement therapy. Sponsored by: Catalent |
Whitepaper Learn more about how the transition from early to late phase of a small molecule program plays a pivotal role in a program’s ultimate success. Sponsored by: Catalent |
Whitepaper Explore how Thermo Scientific’s Process Liquid Preparation Services can help you plan for scalable buffer preparation. Sponsored by: Thermo Fisher Scientific |
eBook Orally Inhaled & Nasal Drug Delivery: A Pipeline of Opportunities Sponsored by: Catalent |
Whitepaper Did you know Catalent has newly expanded in-house capabilities spanning clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays? Sponsored by: Catalent |
Whitepaper What are key considerations for intranasal delivery in the treatment of acute and chronic conditions? Sponsored by: Catalent |
| |
|
